Latest Content by PharmaCompass
KEY PRODUCTS
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
About
Industry Trade Show
Not Confirmed
09-11 April, 2025
BIO International Conv...BIO International Convention
Industry Trade Show
Booth #3435
16-19 June, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #11.1F56
28-30 October, 2025
CONTACT DETAILS
Digital content 
CORPORATE CONTENT #SupplierSpotlight
NEWS #PharmaBuzz
10 Dec 2024
// GLOBENEWSWIRE
15 Jan 2021
// PRESS RELEASE
12 Jun 2020
// PRESS RELEASE
07 May 2020
// PRESS RELEASE
27 Mar 2020
// PRESS RELEASE
USDMF
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-12
Pay. Date : 2013-02-11
DMF Number : 24353
Submission : 2011-01-10
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-09-27
Pay. Date : 2019-09-13
DMF Number : 21584
Submission : 2008-04-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-17
Pay. Date : 2016-11-10
DMF Number : 26081
Submission : 2012-05-14
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-10
Pay. Date : 2013-08-16
DMF Number : 17445
Submission : 2004-06-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2024-01-24
Pay. Date : 2023-04-27
DMF Number : 37429
Submission : 2023-05-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2021-07-15
Pay. Date : 2021-04-06
DMF Number : 35765
Submission : 2021-04-12
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-27
Pay. Date : 2013-02-08
DMF Number : 22289
Submission : 2008-12-08
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Numbers : CEP 2022-093 - Rev 01
Status : Valid
Issue Date : 2024-11-25
Type : Chemical
Substance Number : 2230
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Product Name : KMN-159
Product Type : Small molecule
Upfront Cash : Undisclosed
September 16, 2021
Lead Product(s) : Antibody
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : SBIR
Deal Size : Undisclosed
Deal Type : Funding
Cayman Receives SBIR Grant for Alzheimer’s Research
Details : The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Product Name : Undisclosed
Product Type : Large molecule
Upfront Cash : Undisclosed
October 08, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KEY PRODUCTS
TOP RANKED SUPPLIER FOR:
Analytical Testing Services
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Analytical Method Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Scale Up
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]GMP Manufacturing
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Contract Manufacturing
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Custom Synthesis & Manufacturing
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Process Development & Optimization
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Development
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
Pharma Service : API & Drug Product Development
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
Pharma Service : API & Drug Product Development
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
Pharma Service : API & Drug Product Development
Cayman Pharma is Europe's most reliable and versatile source for Prostaglandin APIs//FDA approved.
Pharma Service : API & Drug Product Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KEY SERVICES
TOP RANKED SUPPLIER FOR:
ABOUT THIS PAGE
Cayman Pharma s.r.o is a supplier offers 8 products (APIs, Excipients or Intermediates).
Find a price of Epoprostenol Sodium bulk with DMF, JDMF offered by Cayman Pharma s.r.o
Find a price of Latanoprost bulk with DMF, JDMF offered by Cayman Pharma s.r.o
Find a price of Travoprost bulk with DMF, JDMF offered by Cayman Pharma s.r.o
Find a price of Bimatoprost bulk with DMF offered by Cayman Pharma s.r.o
Find a price of Latanoprostene Bunod bulk with DMF offered by Cayman Pharma s.r.o
Find a price of Tafluprost bulk with DMF offered by Cayman Pharma s.r.o
Find a price of Cloprostenol Sodium bulk offered by Cayman Pharma s.r.o
Find a price of Psilocybine bulk offered by Cayman Pharma s.r.o
